PreComb Therapeutics


Finding the right treatment for every cancer patient. This is the goal of PreComb, a start-up based in Hombrechtikon and headed by Jens M. Kelm, CEO, Peter Steiner, COO, and Olivier Mauti, CTO.
Cancer is a severe disease affecting more than 10 mio patients every year. A wide range of medicines is currently available for different types of cancer.
PreComb’s innovative 3DTwin® platform brings functional precision medicine into the clinic using patient’s biopsies to predict drug response and to identify effective therapy.
The platform allows patients to be conveniently tested in a global clinical drug testing network driving the paradigm shift towards data-driven cancer therapy recommendations.